Jc. Reverter et al., EFFECTS OF HUMAN MONOCLONAL ANTICARDIOLIPIN ANTIBODIES ON PLATELET-FUNCTION AND ON TISSUE FACTOR EXPRESSION ON MONOCYTES, Arthritis and rheumatism, 41(8), 1998, pp. 1420-1427
Objective. To investigate the effect of human monoclonal anticardiolip
in antibodies (aCL) on platelet interaction with the subendothelium un
der flow conditions and on tissue factor (TF) expression on normal mon
ocytes. Methods. Three monoclonal IgM aCL (TM1B3, GR1D5, and EY2C9) an
d 2 affinity-purified IgM aCL were studied, Immunoglobulins were added
to normal blood and perfused through chambers containing denuded vasc
ular segments. Platelet interactions were morphometrically evaluated b
y determining the percentage of total surface covered by platelets (PC
S) or by large aggregates of thrombi platelets (TP). Expression of TP
on monocytes was measured after immunoglobulin incubation with normal
mononuclear cells. Results. Significant increases in the total PCS and
expression of TP mere observed using all aCL, Increased Bevels of TP
were induced by all aCL except EY2C9 (obtained from a patient without
thrombosis). Previous incubations of these aCL with subendothelial sur
faces did not increase platelet interaction. Conclusion. The effects o
f aCL on platelet function may help to explain the pathophysiology of
thrombosis in the antiphospholipid syndrome.